Business

January 31, 2014

FDA accepts Salix’s latest new drug application

Salix Pharmaceuticals announced this week that the Food and Drug Administration has accepted its new drug application for Budesonide, a rectal foam used to treat patients with ulcerative colitis.

Related content

Comments

Videos

Editor's Choice Videos